One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-147599
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 8 |
Affiliation: Medical College of Wisconsin, University of California, San Francisco, Dana-Farber Cancer Institute, Harvard University, Icahn School of Medicine at Mount Sinai, Swedish Medical Center, Memorial Sloan Kettering Cancer Center, Northwestern University, University of North Carolina at Chapel Hill, Fred Hutch Cancer Center, University of Washington, Loxo Oncology at Lilly (United States), The Ohio State University, St James's University Hospital, Columbia University Irving Medical Center, Churchill Hospital, University of Oxford, Instytut Hematologii i Transfuzjologi, Linear Clinical Research, Sir Charles Gairdner Hospital, Sylvester Comprehensive Cancer Center, University of Miami, Mary Crowley Cancer Research Center, Derriford Hospital, University Hospitals Plymouth NHS Trust, Northwell Health, Sarah Cannon, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, University of Melbourne, The Maria Sklodowska-Curie National Research Institute of Oncology, University of Pennsylvania, UPMC Hillman Cancer Center, The University of Texas MD Anderson Cancer Center, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Cleveland Clinic, Emory UniversityPirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Updated Results from the Phase 1/2 BRUIN Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
